Divisions of Ophthalmology, Cincinnati Children's Hospital Research Foundation, Cincinnati, Ohio USA.
Otolaryngol Head Neck Surg. 2013 Sep;149(3):478-87. doi: 10.1177/0194599813493075. Epub 2013 Jun 14.
To identify the genetic cause of prelingual sensorineural hearing loss in Pakistani families using a next-generation sequencing (NGS)-based mutation screening test named OtoSeq.
Prospective study.
Research laboratory.
We used 3 fluorescently labeled short tandem repeat (STR) markers for each of the known autosomal recessive nonsyndromic (DFNB) and Usher syndrome (USH) locus to perform a linkage analysis of 243 multigenerational Pakistani families segregating prelingual hearing loss. After genotyping, we focused on 34 families with potential linkage to MYO7A, CDH23, and SLC26A4. We screened affected individuals from a subset of these families using the OtoSeq platform to identify underlying genetic variants. Sanger sequencing was performed to confirm and study the segregation of mutations in other family members. For novel mutations, normal hearing individuals from ethnically matched backgrounds were also tested.
Hearing loss was found to co-segregate with locus-specific STR markers for MYO7A in 32 families, CDH23 in 1 family, and SLC26A4 in 1 family. Using the OtoSeq platform, a microdroplet PCR-based enrichment followed by NGS, we identified mutations in 28 of the 34 families including 11 novel mutations. Sanger sequencing of these mutations showed 100% concordance with NGS data and co-segregation of the mutant alleles with the hearing loss phenotype in the respective families.
Using NGS-based platforms like OtoSeq in families segregating hearing loss will contribute to the identification of common and population-specific mutations, early diagnosis, genetic counseling, and molecular epidemiology.
使用基于下一代测序(NGS)的突变筛查测试 OtoSeq 鉴定巴基斯坦家族中先天性感音神经性听力损失的遗传原因。
前瞻性研究。
研究实验室。
我们使用 3 个荧光标记的短串联重复(STR)标记物对每个已知常染色体隐性非综合征(DFNB)和 Usher 综合征(USH)基因座进行连锁分析,对 243 个多代巴基斯坦家族进行连锁分析,这些家族存在先天性听力损失。在基因分型后,我们专注于与 MYO7A、CDH23 和 SLC26A4 具有潜在连锁的 34 个家族。我们使用 OtoSeq 平台对这些家族的一部分受影响个体进行筛选,以鉴定潜在的遗传变异。对其他家族成员进行 Sanger 测序以确认和研究突变的分离。对于新突变,还对来自种族匹配背景的正常听力个体进行了测试。
在 32 个家族中发现听力损失与 MYO7A 特异性 STR 标记物共分离,在 1 个家族中与 CDH23 共分离,在 1 个家族中与 SLC26A4 共分离。使用基于微滴式 PCR 的 OtoSeq 平台进行 NGS 前的富集,我们在 34 个家族中的 28 个家族中鉴定了突变,包括 11 个新突变。对这些突变的 Sanger 测序显示,与 NGS 数据的一致性为 100%,并且突变等位基因与各自家族的听力损失表型共分离。
在存在听力损失的家族中使用基于 NGS 的平台(如 OtoSeq)将有助于鉴定常见和特定人群的突变、早期诊断、遗传咨询和分子流行病学。